These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 3411822)
1. Effects of OKY-046, a selective thromboxane A2 synthetase inhibitor, on ventricular arrhythmias and prostaglandins during coronary artery ligation and reperfusion in anesthetized dogs. Ogura T; Watanabe I; Saito T; Saito S; Ozawa Y; Hatano M Jpn J Pharmacol; 1988 May; 47(1):95-8. PubMed ID: 3411822 [TBL] [Abstract][Full Text] [Related]
2. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity. Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195 [TBL] [Abstract][Full Text] [Related]
3. Effect of thromboxane synthetase inhibitors (OKY-046, OKY-1580) on experimentally induced air embolism in anesthetized dogs. Ishihara Y; Uchida Y; Kitamura S Prostaglandins Leukot Med; 1986 Feb; 21(2):197-206. PubMed ID: 3457388 [TBL] [Abstract][Full Text] [Related]